The scheduling of COVID-19 vaccinations was discussed at a recent meeting of the CDC’s ACIP meeting, where efficacy, safety, and coverage were also reviewed. Although updates to the vaccination schedule were discussed, no changes were made. Providers are advised to continue using monovalent products for the primary series and encourage patients to receive the updated bivalent booster at least two months after completing the primary series.

PDPH recommends that providers continue to order monovalent vaccines to ensure community members can access vaccination. Please see the visual below for quick reference to the COVID-19 Vaccination schedule for individuals who are not moderately or severely immunocompromised.